Lv5
890 积分 2023-08-27 加入
Safety and efficacy of PEG-rhG-CSF as primary prophylaxis for neutropenia in gastrointestinal cancer patients receiving combination chemotherapy including oral agents: a prospective, exploratory, non-randomized controlled study
1个月前
已完结
The Pharmacokinetics and Pharmacodynamics of Irbesartan in Heart Failure
2个月前
已完结
Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma
4个月前
已完结
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
5个月前
已完结
Childhood Liver Cancer Treatment (PDQ®): Health Professional Version
7个月前
已关闭
N6 -Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
7个月前
已完结
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers
1年前
已完结
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
1年前
已完结
皖公网安备34019202002308
